ArticleCancer medicine2023

BRD9 is an essential regulator of glycolysis that creates an epigenetic vulnerability in colon adenocarcinoma.

Qunshan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.